Published in J Bone Miner Res on May 01, 1994
Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates. J Bone Miner Res (2008) 2.42
Functional inhibition of osteoblastic cells in an in vivo mouse model of myeloid leukemia. Blood (2011) 2.27
Spinal metastasis in the elderly. Eur Spine J (2003) 1.46
Bisphosphonates inhibit the adhesion of breast cancer cells to bone matrices in vitro. J Clin Invest (1996) 1.44
Comparative effectiveness on survival of zoledronic acid versus pamidronate in multiple myeloma. Leuk Lymphoma (2014) 1.41
Oral ibandronate reduces the risk of skeletal complications in breast cancer patients with metastatic bone disease: results from two randomised, placebo-controlled phase III studies. Br J Cancer (2004) 1.38
Osteoclasts in multiple myeloma are derived from Gr-1+CD11b+myeloid-derived suppressor cells. PLoS One (2012) 1.25
Structure-based design of an osteoclast-selective, nonpeptide src homology 2 inhibitor with in vivo antiresorptive activity. Proc Natl Acad Sci U S A (2000) 1.22
Zoledronic acid induces antiproliferative and apoptotic effects in human pancreatic cancer cells in vitro. Br J Cancer (2003) 1.21
Zoledronic acid in the management of metastatic bone disease. Ther Clin Risk Manag (2008) 0.97
Randomized trial of adjuvant zoledronic acid in postmenopausal women with high-risk breast cancer. Clin Breast Cancer (2010) 0.93
Aromatase inhibitors and bone loss. Oncology (Williston Park) (2006) 0.92
Targeting bone metastases in prostate cancer: improving clinical outcome. Nat Rev Urol (2015) 0.92
Detecting early bone changes using in vivo micro-CT in ovariectomized, zoledronic acid-treated, and sham-operated rats. Osteoporos Int (2009) 0.91
RisedronatE and ALendronate Intervention over Three Years (REALITY): minimal differences in fracture risk reduction. Osteoporos Int (2008) 0.91
Combined effects of the bisphosphonate, zoledronic acid and the aromatase inhibitor letrozole on breast cancer cells in vitro: evidence of synergistic interaction. Br J Cancer (2010) 0.91
Loss of vertebral bone and mechanical strength in estrogen-deficient rats is prevented by long-term administration of zoledronic acid. Osteoporos Int (2004) 0.89
Risk of renal impairment after treatment with ibandronate versus zoledronic acid: a retrospective medical records review. Support Care Cancer (2008) 0.89
Early treatment with zoledronic acid prevents bone loss at the hip following acute spinal cord injury. Osteoporos Int (2010) 0.87
Once-yearly zoledronic acid in hip fracture prevention. Clin Interv Aging (2009) 0.86
Hypercalcemia of malignancy and new treatment options. Ther Clin Risk Manag (2015) 0.85
Targeted treatments of bone metastases in patients with lung cancer. Front Oncol (2014) 0.85
Zoledronic acid in metastatic chondrosarcoma and advanced sacrum chordoma: two case reports. J Exp Clin Cancer Res (2009) 0.84
Zoledronate in a patient with pamidronate refractory hypercalcemia syndrome. Support Care Cancer (2004) 0.80
Aquabis[1-hydroxy-2-(imidazol-3-ium-1-yl)-1,1'-ethylidenediphophonato-κO,O']zinc(II) dihydrate. Acta Crystallogr Sect E Struct Rep Online (2009) 0.80
Diaqua-bis[1-hydroxy-2-(imidazol-3-ium-1-yl)-1,1'-ethyl-idenediphophonato-κO,O']zinc(II). Acta Crystallogr Sect E Struct Rep Online (2009) 0.80
Inhibition of inflammatory actions of aminobisphosphonates by dichloromethylene bisphosphonate, a non-aminobisphosphonate. Br J Pharmacol (1999) 0.80
CCN1, a candidate target for zoledronic acid treatment in breast cancer. Mol Cancer Ther (2011) 0.79
Contrast between effects of aminobisphosphonates and non-aminobisphosphonates on collagen-induced arthritis in mice. Br J Pharmacol (1996) 0.79
Use of zoledronic acid in the treatment of Paget's disease. Ther Clin Risk Manag (2007) 0.78
Osteonecrosis of the jaws: clinicopathologic and radiologic characteristics, preventive and therapeutic strategies. Strahlenther Onkol (2010) 0.76
Treatment of postmenopausal osteoporosis, patient perspectives - focus on once yearly zoledronic acid. Patient Prefer Adherence (2009) 0.76
Importance of antiresorptive therapies for patients with bone metastases from solid tumors. Cancer Manag Res (2012) 0.76
The use of zoledronic acid in Japanese men with stage D2 prostate cancer. Oncol Lett (2010) 0.75
The Effect of Bisphosphonates on Bone Mineral Density in Metastatic Prostate Cancer Patients Who Are Treated with Anti-Androgen Drugs and Radiotherapy. Curr Urol (2014) 0.75
Absorbed dose assessment of (177)Lu-zoledronate and (177)Lu-EDTMP for human based on biodistribution data in rats. J Med Phys (2015) 0.75
A meta-analysis characterizing the dose-response relationships for three oral nitrogen-containing bisphosphonates in postmenopausal women. Osteoporos Int (2012) 0.75
A promising approach for treatment of tumor-induced bone diseases: utilizing bisphosphonate derivatives of nucleoside antimetabolites. Bone (2010) 0.75
In vitro potency, in vitro and in vivo efficacy of liposomal alendronate in combination with γδ T cell immunotherapy in mice. J Control Release (2016) 0.75
Varus deformity of the left lower extremity causing degenerative lesion of the posterior horn of the left medial meniscus in a patient with Paget's disease of bone. Ger Med Sci (2014) 0.75
Osteoporosis treatment with zoledronic acid in pediatric population at a university hospital in Western Saudi Arabia. A 13-year experience. Saudi Med J (2015) 0.75
Zoledronic acid for prevention of bone loss in patients receiving primary therapy for lymphomas: a prospective, randomized controlled phase III trial. Clin Lymphoma Myeloma Leuk (2012) 0.75
Bone-targeted therapy in metastatic breast cancer - all well-established knowledge? Breast Care (Basel) (2014) 0.75
Current options for the treatment of Paget's disease of the bone. Open Access Rheumatol (2009) 0.75
Anti-cancer effects of nitrogen-containing bisphosphonates on human cancer cells. Oncotarget (2016) 0.75
Bone health in nonmetastatic prostate cancer: what's the big deal? Curr Oncol (2010) 0.75
Bisphosphonate therapy for women with breast cancer and at high risk for osteoporosis. J Natl Med Assoc (2007) 0.75
Small-Molecule Screens: A Gateway to Cancer Therapeutic Agents with Case Studies of Food and Drug Administration-Approved Drugs. Pharmacol Rev (2017) 0.75
Clonal descent and microevolution of Neisseria meningitidis during 30 years of epidemic spread. Mol Microbiol (1997) 3.79
On the origin and domestication history of Barley (Hordeum vulgare). Mol Biol Evol (2000) 2.94
A specific glycoprotein as the target site of adhesion blocking Fab in aggregating Dictyostelium cells. Nature (1978) 2.64
MAB, a generally applicable molecular force field for structure modelling in medicinal chemistry. J Comput Aided Mol Des (1995) 2.34
Smallest angiosperm genomes found in lentibulariaceae, with chromosomes of bacterial size. Plant Biol (Stuttg) (2006) 2.12
Changes in phosphocreatine concentration of skeletal muscle during high-intensity intermittent exercise in children and adults. Eur J Appl Physiol (2013) 2.00
LIPSIA--a new software system for the evaluation of functional magnetic resonance images of the human brain. Comput Med Imaging Graph (2001) 1.90
HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species. Hypertension (2001) 1.84
Inhibition of geranylgeranylation reduces angiotensin II-mediated free radical production in vascular smooth muscle cells: involvement of angiotensin AT1 receptor expression and Rac1 GTPase. Mol Pharmacol (2001) 1.51
Structure and thermodynamics of the dihexadecylphosphatidylcholine-water system. Chem Phys Lipids (1987) 1.50
Strong constraints on the rare decays B(s)(0) → μ+ μ- and B0 → μ+ μ-. Phys Rev Lett (2012) 1.50
First observation of the decays B(0) → D(+)K(-)π(+)π(-) and B(-) → D(0)K(-)π(+)π(-). Phys Rev Lett (2012) 1.50
Analysis of the first complete DNA sequence of an invertebrate iridovirus: coding strategy of the genome of Chilo iridescent virus. Virology (2001) 1.45
Differential phosphorylation of the nucleoprotein of influenza A viruses. J Gen Virol (1989) 1.45
Determination of the X(3872) meson quantum numbers. Phys Rev Lett (2013) 1.42
Mast cell sarcoma of the larynx. J Clin Pathol (1986) 1.41
Interferon treatment of patients with chronic urticaria and mastocytosis. J Am Acad Dermatol (1994) 1.39
[Retro- and prospective studies on the value of clinical and laboratory chemical data in acute appendicitis]. Chirurg (1990) 1.38
An activation-independent role of transcription factors in insulator function. EMBO Rep (2001) 1.32
Color-word matching stroop task: separating interference and response conflict. Neuroimage (2001) 1.32
Tetravalent miniantibodies with high avidity assembling in Escherichia coli. J Mol Biol (1995) 1.24
Early gene expression of NK cell-activating chemokines in mice resistant to Leishmania major. Infect Immun (1999) 1.21
First observation of CP violation in the decays of B(s)0 mesons. Phys Rev Lett (2013) 1.21
Structural dimorphism of bile salt/lecithin mixed micelles. A possible regulatory mechanism for cholesterol solubility in bile? X-ray structure analysis. Biochemistry (1981) 1.19
A membrane glycoprotein of aggregating Dictyostelium cells with the properties of contact sites. Eur J Biochem (1979) 1.17
Reconstitution of lactic dehydrogenase from pig heart after reversible high-pressure dissociation. Biochemistry (1981) 1.15
Mycobacterium hiberniae sp. nov. Int J Syst Bacteriol (1993) 1.11
[Possible influences of sodium nitroprusside and its metabolites on the carbohydrate and energy metabolism in intraocular surgery]. Med Welt (1981) 1.11
Recruitment of contralesional motor cortex in stroke patients with recovery of hand function. Neurology (2005) 1.11
Pressure-induced structural changes of pig heart lactic dehydrogenase. Biophys Chem (1981) 1.10
Thermal phase behaviour and structure of hydrated mixtures between dipalmitoyl- and dihexadecylphosphatidylcholine. Chem Phys Lipids (1987) 1.10
BK virus-specific immunity kinetics: a predictor of recovery from polyomavirus BK-associated nephropathy. Am J Transplant (2011) 1.09
Accurate diagnosis of acute appendicitis: a retrospective and prospective analysis of 686 patients. Eur J Surg (1992) 1.09
Use of an ex vivo ATP luminescence assay to direct chemotherapy for recurrent ovarian cancer. Anticancer Drugs (1998) 1.08
Mutants and revertants of an avian influenza A virus with temperature-sensitive defects in the nucleoprotein and PB2. Virology (1991) 1.05
Studies on the structure of lipoprotein A of human high density lipoprotein HDL3: the spherically averaged electron density distribution. FEBS Lett (1973) 1.03
The fate of foreign DNA in mammalian cells and organisms. Dev Biol (Basel) (2001) 1.02
On-chip time resolved detection of quantum dot emission using integrated superconducting single photon detectors. Sci Rep (2013) 1.02
Aqueous extracts from dentin adhesives contain cytotoxic chemicals. J Biomed Mater Res (1999) 1.02
Biophysical characterisation of electrofused giant HEK293-cells as a novel electrophysiological expression system. Biochem Biophys Res Commun (2006) 1.01
Anti-oxidative capacity in patients with ataxia telangiectasia. Clin Exp Immunol (1999) 1.01
Haemosporidian blood parasites in European birds of prey and owls. J Parasitol (2008) 1.00
Interleukin-1 enhances pain reflexes. Mediation through increased prostaglandin E2 levels. Agents Actions (1988) 1.00
Differential effect of conditioning regimens on cytokine responses during allogeneic stem cell transplantation. Bone Marrow Transplant (2006) 1.00
High volumetric yields of functional dimeric miniantibodies in Escherichia coli, using an optimized expression vector and high-cell-density fermentation under non-limited growth conditions. Appl Microbiol Biotechnol (1996) 0.99
[Development and validation of assessment instruments for shared decision making]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz (2004) 0.98
Demonstration of Borrelia burgdorferi infection in a child with Guillain-Barré syndrome. Eur J Pediatr (1993) 0.98
Halothane-induced variability in the neuromuscular transmission of patients with myasthenia gravis. Acta Anaesthesiol Scand (1989) 0.97
[Identification and determination of polyvinylpyrrolidone(PVP) as well as determination of active substances in PVP-containing drug preparations]. Pharm Acta Helv (1969) 0.96
Measurement of form-factor-independent observables in the decay B0→K(*0)μ(+)μ(-). Phys Rev Lett (2013) 0.96
Association between genetic polymorphisms in the human interleukin-7 receptor alpha-chain and inhalation allergy. Int J Immunogenet (2007) 0.96
Lichen metabolites. 1. Inhibitory action against leukotriene B4 biosynthesis by a non-redox mechanism. J Nat Prod (1999) 0.96
Foreign DNA integration--perturbations of the genome--oncogenesis. Ann N Y Acad Sci (2001) 0.95
Medicinal plants from nepal: evaluation as inhibitors of leukotriene biosynthesis. J Ethnopharmacol (2000) 0.95
Observation of a resonance in B+ → K+ μ+ μ- decays at low recoil. Phys Rev Lett (2013) 0.95
Monitoring of West Nile virus infections in Germany. Zoonoses Public Health (2012) 0.95
Comparative analysis of the genome and host range characteristics of two insect iridoviruses: Chilo iridescent virus and a cricket iridovirus isolate. J Gen Virol (2002) 0.94
A triglobular model for the polypeptide chain of aspartokinase I-homoserine dehydrogenase I of Escherichia coli. Biochemistry (1983) 0.94
Accumulation of macrophages in the CSF of schizophrenic patients during acute psychotic episodes. Am J Psychiatry (1999) 0.94
Myasthenia gravis associated with multiple sclerosis. Epidemiological survey and immunological findings. J Neurol Sci (1989) 0.94
Expression analysis of ataxin-7 mRNA and protein in human brain: evidence for a widespread distribution and focal protein accumulation. Brain Pathol (2000) 0.94
Multicentre, phase II trial on the safety and efficacy of topical tacrolimus ointment for the treatment of lichen sclerosus. Br J Dermatol (2006) 0.93
Evaluation of a simplified dual-platform flow cytometric method for measurement of lymphocyte subsets and T-cell maturation phenotypes in the population of Nouna, Burkina Faso. Clin Vaccine Immunol (2007) 0.93
Separating distractor rejection and target detection in posterior parietal cortex--an event-related fMRI study of visual marking. Neuroimage (2003) 0.93
Resuscitating the heart but losing the brain: brain atrophy in the aftermath of cardiac arrest. Neurology (2010) 0.92
DNA and RNA virus species are inhibited by xanthates, a class of antiviral compounds with unique properties. Proc Natl Acad Sci U S A (1984) 0.92
Olfactory orientation in frogs. Naturwissenschaften (1976) 0.92
Genetic polymorphisms in the genes encoding human interleukin-7 receptor-alpha: prognostic significance in allogeneic stem cell transplantation. Bone Marrow Transplant (2006) 0.92
Phonological processing during language production: fMRI evidence for a shared production-comprehension network. Brain Res Cogn Brain Res (2003) 0.91
Creatine has no beneficial effect on skeletal muscle energy metabolism in patients with single mitochondrial DNA deletions: a placebo-controlled, double-blind 31P-MRS crossover study. Eur J Neurol (2005) 0.91
The organization structure and regulatory elements of Chlamydomonas histone genes reveal features linking plant and animal genes. Curr Genet (1995) 0.91
A new type of corrin synthesis. Angew Chem Int Ed Engl (1969) 0.90
Denaturation and renaturation of bovine liver glutamic dehydrogenase after dissociation in various denaturants. Z Naturforsch C (1980) 0.90
Structure and expression of a single actin gene in Volvox carteri. Curr Genet (1990) 0.90
Immunogenicity and evolutionary variability of epitopes within IgA1 protease from serogroup A Neisseria meningitidis. Mol Microbiol (1994) 0.90
Design and synthesis of potent and highly selective thrombin inhibitors. J Med Chem (1994) 0.90
Inhibition of keratinocyte growth by different Nepalese zanthoxylum species. Phytother Res (1999) 0.90
Benzophenanthridine alkaloids of Chelidonium majus; I. Inhibition of 5- and 12-lipoxygenase by a non-redox mechanism. Planta Med (1996) 0.89
The structure of human-plasma low-density lipoprotein B. An X-ray small-angle scattering study. Eur J Biochem (1978) 0.89
Thermodynamics and mechanism of high-pressure deactivation and dissociation of porcine lactic dehydrogenase. Biophys Chem (1982) 0.89
L-carnitine and creatine in Friedreich's ataxia. A randomized, placebo-controlled crossover trial. J Neural Transm (Vienna) (2004) 0.89
Five-year outcome after mild head injury: a prospective controlled study. Acta Neurol Scand (2007) 0.89
Familial aggregation of spelling disability. J Child Psychol Psychiatry (1996) 0.89
The effect of an irregular shift system on sleepiness at work in train drivers and railway traffic controllers. J Sleep Res (2002) 0.89
Differences between 'congenital mirror movements' and 'associated movements' in normal children: a neurophysiological case study. Neurosci Lett (1998) 0.89
X-ray small angle scattering of human plasma high density lipoprotein LpA from HDL2: application of a new evaluation method. FEBS Lett (1974) 0.88
Medicinal plants from Nepal; II. Evaluation as inhibitors of lipid peroxidation in biological membranes. J Ethnopharmacol (1999) 0.87
Synthesis and properties of fluorescent beta-adrenoceptor ligands. Biochemistry (1994) 0.87
TNF and LT binding capacities in the plasma of arthritis patients: effect of etanercept treatment in juvenile idiopathic arthritis. Clin Exp Rheumatol (2004) 0.87
Isolation of Mycobacterium simiae from the environment. Zentralbl Bakteriol (1992) 0.87
Increased frequency of activated lymphocytes in the cerebrospinal fluid of patients with acute schizophrenia. Schizophr Res (2001) 0.87
[Dextran 40 or HES 200/0.5? Hemorheology of the long-term treatment of ischemic cerebral attacks]. Dtsch Med Wochenschr (1986) 0.86
The construction of new proteins: V. A template-assembled synthetic protein (TASP) containing both a 4-helix bundle and beta-barrel-like structure. Proteins (1989) 0.86
Mesenchymal stem cells in cartilage repair: state of the art and methods to monitor cell growth, differentiation and cartilage regeneration. Curr Med Chem (2010) 0.86
Randomized, controlled phase II trial of subcutaneous interleukin-2 in combination with highly active antiretroviral therapy (HAART) in HIV patients. AIDS (1998) 0.86
The Linderniaceae and Gratiolaceae are further lineages distinct from the Scrophulariaceae (Lamiales). Plant Biol (Stuttg) (2005) 0.86
Influence of the bovine seminal plasma protein PDC-109 on the physical state of membranes. Biochemistry (2001) 0.86
Biophysical characterization of the interaction of bovine seminal plasma protein PDC-109 with phospholipid vesicles. Eur Biophys J (1998) 0.86